Early Intra-Aortic Balloon Pump Support and In-Hospital Mortality in Patients with LV Dysfunction and Cardiogenic...

Area of Science:

• Cardiology
• Critical Care Medicine
• Cardiovascular Surgery

Background:

• Cardiogenic shock (CS) following acute myocardial infarction (AMI) carries a high mortality rate despite mechanical support (MCS) advancements.
• Severe left ventricular (LV) systolic dysfunction is a key factor in CS prognosis.
• Evaluating the efficacy of early intra-aortic balloon pump (IABP) support is crucial for improving outcomes.

Purpose of the Study:

• To assess the effectiveness of early IABP support versus medical therapy in patients with AMI-CS and severe LV dysfunction.
• To determine if the timing of IABP initiation impacts in-hospital mortality.
• To compare the need for advanced MCS between early IABP and medical therapy groups.

Main Methods:

• Analysis of the RESCUE I registry, a multicenter cohort of 1247 CS patients.
• Inclusion of 192 patients with AMI-CS and LVEF ≤ 35%, divided into medical therapy (n=105) and IABP support (n=87) groups.
• Comparison of in-hospital mortality, focusing on early IABP initiation (shock-to-IABP < 2 hours) versus medical therapy.

Main Results:

• Overall in-hospital mortality was 42.2%.
• Early IABP initiation (< 2 hours) significantly reduced mortality (32.0% vs. 47.6%, p=0.036) compared to medical therapy.
• IABP use was associated with a significantly lower need for advanced MCS (4.6% vs. 22.9%, p<0.001).

Conclusions:

• Early IABP support, initiated within 2 hours of shock onset, improves survival in AMI-CS patients with severe LV dysfunction.
• The timing of IABP intervention is critical, suggesting a selective rather than routine approach.
• Early IABP reduces the requirement for more advanced mechanical circulatory support devices.